Quest Diagnostics DGX
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Quest Diagnostics (DGX) Core Market Data and Business Metrics
Latest Closing Price
$169.28Price-Earnings Ratio
22.01Total Outstanding Shares
110.98 Million SharesDividend
$0.80 Per Share QuarterlySIC Description
Services-medical LaboratoriesPrimary Exchange
New York Stock ExchangeHeadquarters
500 Plaza Drive, Secaucus, NJ, 07094
Historical Stock Splits
If you bought 1 share of DGX before June 21, 2005, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| June 21, 2005 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,340,339 Shares | 2.06 | 3/14/2025 | 2,762,021 Shares |
| 1,148,470 Shares | 2.23 | 2/28/2025 | 2,565,047 Shares |
| 981,369 Shares | 3.01 | 2/14/2025 | 2,956,503 Shares |
| 1,326,439 Shares | 1.95 | 1/31/2025 | 2,580,994 Shares |
| 716,796 Shares | 3.17 | 1/15/2025 | 2,269,910 Shares |
| 722,593 Shares | 2.81 | 12/31/2024 | 2,032,747 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $1.33 Billion |
| Net Cash Flow From Financing Activities, Continuing | $1.08 Billion |
| Net Cash Flow | $-137 Million |
| Net Cash Flow From Operating Activities | $1.33 Billion |
| Net Cash Flow, Continuing | $-130 Million |
| Net Cash Flow From Investing Activities | $-2.55 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Selling, General, and Administrative Expenses | $1.77 Billion |
| Net Income/Loss | $921 Million |
| Gross Profit | $3.24 Billion |
| Income Tax Expense/Benefit | $273 Million |
| Diluted Earnings Per Share | $7.69 |
| Basic Average Shares | $111 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $50 Million |
| Comprehensive Income/Loss | $847 Million |
| Comprehensive Income/Loss Attributable To Parent | $797 Million |
| Other Comprehensive Income/Loss | $-74 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Non-current Liabilities | $871 Million |
| Other Non-current Assets | $9.88 Billion |
| Equity Attributable To Noncontrolling Interest | $35 Million |
| Other Current Assets | $2.20 Billion |
| Noncurrent Liabilities | $7.09 Billion |
| Liabilities And Equity | $16.15 Billion |
Historical Dividends
Current dividend: $0.80 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 30, 2025 | Apr 21, 2025 | Apr 7, 2025 | $0.8 | Quarterly |
| Nov 12, 2024 | Jan 29, 2025 | Jan 14, 2025 | $0.75 | Quarterly |
| Aug 14, 2024 | Oct 21, 2024 | Oct 4, 2024 | $0.75 | Quarterly |
| May 15, 2024 | Jul 22, 2024 | Jul 8, 2024 | $0.75 | Quarterly |
| Feb 1, 2024 | Apr 22, 2024 | Apr 8, 2024 | $0.75 | Quarterly |
| Nov 13, 2023 | Jan 31, 2024 | Jan 17, 2024 | $0.71 | Quarterly |